Study of 6b11-OCIK Injection Treatment in Patients With Recurrent Drug-resistant Ovarian Cancer
Clinical trial NCT03542669 · UNKNOWN
Trial details
- NCT number
- NCT03542669
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-03
- Primary completion
- 2022-12-30
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.